Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients

BMC Infectious Diseases
http://www.biomedcentral.com/bmcinfectdis/content
(Accessed 8 May 2021)

 

Evaluation of the effectiveness and safety of adding ivermectin to treatment in severe COVID-19 patients
An effective treatment option is not yet available for SARS-CoV2, which causes the COVID-19 pandemic and whose effects are felt more and more every day. Ivermectin is among the drugs whose effectiveness in tre…
Authors: Nurullah Okumuş, Neşe Demirtürk, Rıza Aytaç Çetinkaya, Rahmet Güner, İsmail Yaşar Avcı, Semiha Orhan, Petek Konya, Bengü Şaylan, Ayşegül Karalezli, Levent Yamanel, Bircan Kayaaslan, Gülden Yılmaz, Ümit Savaşçı, Fatma Eser and Gürhan Taşkın
Citation: BMC Infectious Diseases 2021 21:411
Content type: Research
Published on: 4 May 2021